Cellix Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Investors
-
1
Cellix General Information
Description
Manufacturer of microfluidic analytical equipment and instruments designed for cell-based assays, droplet generation, thrombosis, organ-on-a-chip, cell adhesion, and migration processes. The company offers microfluidic syringe pumps, pressure pumps, viability analyzers, cell adhesion biochips, droplet generation devices, and many more, thereby enabling blood centers, stem cell research firms, biofilm culture firms, and pharmaceutical and biotechnology companies to improve flow cytometry, impedance cell analysis, and sorting.
Contact Information
Website
www.wearecellix.com(Operating Subsidiary)
Corporate Office
- Unit 1, Longmile Business Park
- Longmile Road
- Dublin D12 EK79
- Ireland
Corporate Office
- Unit 1, Longmile Business Park
- Longmile Road
- Dublin D12 EK79
- Ireland
Cellix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 20-Jun-2023 | Completed | Generating Revenue | |||
| 3. Grant | 23-Nov-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 21-Oct-2008 | $2.62M | $2.62M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2004 | Completed | Startup |
Cellix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary |
Cellix Patents
Cellix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3871773-A1 | A method of determining the transfection status of a plurality of cells | Active | 27-Feb-2020 | ||
| EP-3871773-B1 | A method of determining the transfection status of a plurality of cells | Active | 27-Feb-2020 | ||
| US-12269035-B2 | Method of determining the transfection status of a plurality of cells | Active | 27-Feb-2020 | ||
| US-20210291186-A1 | Method of determining the transfection status of a plurality of cells | Active | 27-Feb-2020 | ||
| EP-3946733-A1 | A method and device for transfecting cells | Active | 29-Mar-2019 | C12M35/02 |
Cellix Signals
Cellix Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apicap | PE/Buyout | Minority | ||
| Enterprise Ireland | Growth/Expansion | Minority | ||
| Horizon 2020 | Government | |||
| Investec Ventures Ireland | Venture Capital | Minority |
Cellix FAQs
-
When was Cellix founded?
Cellix was founded in 2004.
-
Where is Cellix headquartered?
Cellix is headquartered in Dublin, Ireland.
-
What is the size of Cellix?
Cellix has 11 total employees.
-
What industry is Cellix in?
Cellix’s primary industry is Diagnostic Equipment.
-
Is Cellix a private or public company?
Cellix is a Private company.
-
What is Cellix’s current revenue?
The current revenue for Cellix is .
-
How much funding has Cellix raised over time?
Cellix has raised $2.62M.
-
Who are Cellix’s investors?
Apicap, Enterprise Ireland, Horizon 2020, and Investec Ventures Ireland have invested in Cellix.
-
When was Cellix acquired?
Cellix was acquired on 20-Jun-2023.
-
Who acquired Cellix?
Cellix was acquired by Randox Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process